Skip to main content
SpringerLink
Log in

Changing Populations: The Elderly, Injection Drug Users, Health-Care Associated Endocarditis and Immunocompromised Patients

  • Chapter
  • First Online:
Endocarditis

  • 1005 Accesses

Abstract

The epidemiology of infective endocarditis is changing. The combination of increased life-expectancy, the burden of chronic disease, immunosuppression as a result of improving treatment and prognosis of malignancies and transplantation and the increasing device-related and iatrogenic infections have resulted in risk factors for infectious endocarditis. The etiological agents vary according to the underlying predisposing factors with increases in resistant health-care associated infections among the special populations reviewed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Hoesley CJ, Cobbs CG. Endocarditis at the millennium. J Infect Dis. 1999;179 Suppl 2:S360–5.

    Article  PubMed  Google Scholar 

  2. Griffin MR, et al. Infective endocarditis. Olmsted County, Minnesota, 1950 through 1981. JAMA. 1985;254(9):1199–202.

    Article  CAS  PubMed  Google Scholar 

  3. Tleyjeh IM, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County. Minn JAMA. 2005;293(24):3022–8.

    Article  CAS  PubMed  Google Scholar 

  4. Correa de Sa DD, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2010;85(5):422–6.

    Article  PubMed  Google Scholar 

  5. Desimone DC, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation. 2012;126(1):60–4.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Anderson DJ, et al. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. Infection. 2004;32(2):72–7.

    Article  CAS  PubMed  Google Scholar 

  7. van der Meer JT, et al. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med. 1992;152(9):1863–8.

    Article  PubMed  Google Scholar 

  8. Delahaye F, et al. Characteristics of infective endocarditis in France in 1991. A 1-year survey. Eur Heart J. 1995;16(3):394–401.

    CAS  PubMed  Google Scholar 

  9. Murdoch DR, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Fefer P, et al. Changing epidemiology of infective endocarditis: a retrospective survey of 108 cases, 1990–1999. Eur J Clin Microbiol Infect Dis. 2002;21(6):432–7.

    Article  CAS  PubMed  Google Scholar 

  11. Selton-Suty C, et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart. 1997;77(3):260–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Cabell CH, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162(1):90–4.

    Article  PubMed  Google Scholar 

  13. Hoen B, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288(1):75–81.

    Article  PubMed  Google Scholar 

  14. Slipczuk L, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Weinstein L, Rubin RH. Infective endocarditis – 1973. Prog Cardiovasc Dis. 1973;16(3):239–74.

    Article  CAS  PubMed  Google Scholar 

  16. Durante-Mangoni E, et al. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168(19):2095–103.

    Article  PubMed  Google Scholar 

  17. Benito N, et al. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009;150(9):586–94.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tomas Carmona I, et al. Bacterial endocarditis of oral etiology in an elderly population. Arch Gerontol Geriatr. 2003;36(1):49–55.

    Article  CAS  PubMed  Google Scholar 

  19. Zamorano J, et al. Better prognosis of elderly patients with infectious endocarditis in the era of routine echocardiography and nonrestrictive indications for valve surgery. J Am Soc Echocardiogr. 2002;15(7):702–7.

    Article  PubMed  Google Scholar 

  20. Duval X, et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis. 2004;39(1):68–74.

    Article  PubMed  Google Scholar 

  21. Ramsdale DR, et al. Bacteremia following complex percutaneous coronary intervention. J Invasive Cardiol. 2004;16(11):632–4.

    PubMed  Google Scholar 

  22. Fernandez-Ruiz M, et al. Streptococcus bovis bacteraemia revisited: clinical and microbiological correlates in a contemporary series of 59 patients. J Infect. 2010;61(4):307–13.

    Article  PubMed  Google Scholar 

  23. Hoen B, et al. Emergence of endocarditis due to group D streptococci: findings derived from the merged database of the International Collaboration on Endocarditis. Eur J Clin Microbiol Infect Dis. 2005;24(1):12–6.

    Article  CAS  PubMed  Google Scholar 

  24. Gavazzi G, Herrmann F, Krause KH. Aging and infectious diseases in the developing world. Clin Infect Dis. 2004;39(1):83–91.

    Article  PubMed  Google Scholar 

  25. McDonald JR, et al. Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database. Am J Med. 2005;118(7):759–66.

    Article  CAS  PubMed  Google Scholar 

  26. Chirouze C, et al. Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect. 2013;19(12):1140–7.

    Article  CAS  PubMed  Google Scholar 

  27. Di Salvo G, et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J. 2003;24(17):1576–83.

    Article  PubMed  Google Scholar 

  28. Pergola V, et al. Comparison of clinical and echocardiographic characteristics of Streptococcus bovis endocarditis with that caused by other pathogens. Am J Cardiol. 2001;88(8):871–5.

    Article  CAS  PubMed  Google Scholar 

  29. Thuny F, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation. 2005;112(1):69–75.

    Article  PubMed  Google Scholar 

  30. Bassetti M, et al. Infective endocarditis in elderly: an Italian prospective multi-center observational study. Int J Cardiol. 2014;177(2):636–8.

    Article  PubMed  Google Scholar 

  31. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363(9403):139–49.

    Article  PubMed  Google Scholar 

  32. Netzer RO, et al. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria. Clin Infect Dis. 1999;28(4):933–5.

    Article  CAS  PubMed  Google Scholar 

  33. Gagliardi JP, et al. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke Endocarditis Database. Clin Infect Dis. 1998;26(5):1165–8.

    Article  CAS  PubMed  Google Scholar 

  34. Burke AP, et al. Infectious endocarditis and sudden unexpected death: incidence and morphology of lesions in intravenous addicts and non-drug abusers. J Heart Valve Dis. 1997;6(2):198–203.

    CAS  PubMed  Google Scholar 

  35. Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003;21(2):167–84, v–vi.

    Article  PubMed  Google Scholar 

  36. Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis. 1986;8(3):374–96.

    Article  CAS  PubMed  Google Scholar 

  37. Chambers HF, et al. Cocaine use and the risk for endocarditis in intravenous drug users. Ann Intern Med. 1987;106(6):833–6.

    Article  CAS  PubMed  Google Scholar 

  38. Cooper HL, et al. Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clin Infect Dis. 2007;45(9):1200–3.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Panduranga P, Al-Abri S, Al-Lawati J. Intravenous drug abuse and tricuspid valve endocarditis: growing trends in the Middle East Gulf region. World J Cardiol. 2013;5(11):397–403.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Axelsson A, et al. Echocardiographic findings suggestive of infective endocarditis in asymptomatic Danish injection drug users attending urban injection facilities. Am J Cardiol. 2014;114(1):100–4.

    Article  PubMed  Google Scholar 

  41. Graves MK, Soto L. Left-sided endocarditis in parenteral drug abusers: recent experience at a large community hospital. South Med J. 1992;85(4):378–80.

    Article  CAS  PubMed  Google Scholar 

  42. Carozza A, et al. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15(1):125–31.

    PubMed  Google Scholar 

  43. Mathew J, et al. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995;155(15):1641–8.

    Article  CAS  PubMed  Google Scholar 

  44. Brown PD, Levine DP. Infective endocarditis in the injection drug user. Infect Dis Clin N Am. 2002;16(3):645–65, viii–ix.

    Article  Google Scholar 

  45. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988;109(8):619–24.

    Article  CAS  PubMed  Google Scholar 

  46. Fortun J, et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis. 2001;33(1):120–5.

    Article  CAS  PubMed  Google Scholar 

  47. Ribera E, et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med. 1996;125(12):969–74.

    Article  CAS  PubMed  Google Scholar 

  48. Mathew J, et al. Results of surgical treatment for infective endocarditis in intravenous drug users. Chest. 1995;108(1):73–7.

    Article  CAS  PubMed  Google Scholar 

  49. Kemp CD, et al. Valve surgery for infective endocarditis is associated with high hospital charges. J Heart Valve Dis. 2013;22(1):110–7.

    PubMed  Google Scholar 

  50. Akinosoglou K, et al. Right-sided infective endocarditis: surgical management. Eur J Cardiothorac Surg. 2012;42(3):470–9.

    Article  PubMed  Google Scholar 

  51. Kaiser SP, et al. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg. 2007;83(1):30–5.

    Article  PubMed  Google Scholar 

  52. Fedoruk LM, et al. Predictors of recurrence and reoperation for prosthetic valve endocarditis after valve replacement surgery for native valve endocarditis. J Thorac Cardiovasc Surg. 2009;137(2):326–33.

    Article  PubMed  Google Scholar 

  53. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: current approach and therapeutic options. Prog Cardiovasc Dis. 2008;50(4):274–81.

    Article  PubMed  Google Scholar 

  54. Losa JE, et al. Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect. 2003;9(1):45–54.

    Article  CAS  PubMed  Google Scholar 

  55. Valencia E, Miro J. Endocarditis in the setting of HIV infection. AIDS Rev. 2004;6(2):97–106.

    PubMed  Google Scholar 

  56. Wilson LE, et al. Prospective study of infective endocarditis among injection drug users. J Infect Dis. 2002;185(12):1761–6.

    Article  PubMed  Google Scholar 

  57. Ferraris L, et al. Profile of infective endocarditis observed from 2003–2010 in a single center in Italy. BMC Infect Dis. 2013;13:545.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Gebo KA, et al. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr. 2006;43(4):426–32.

    Article  PubMed  Google Scholar 

  59. Manoff SB, et al. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology. 1996;7(6):566–70.

    Article  CAS  PubMed  Google Scholar 

  60. Miro JM, del Rio A, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin N Am. 2002;16(2):273–95, vii–viii.

    Article  Google Scholar 

  61. Smith DT, et al. A comparison of HIV-positive patients with and without infective endocarditis: an echocardiographic study – the Emory Endocarditis Group experience. Am J Med Sci. 2004;328(3):145–9.

    Article  PubMed  Google Scholar 

  62. Abraham J, Veledar E, Lerakis S. Comparison of frequency of active infective endocarditis by echocardiography in patients with bacteremia with and without human immunodeficiency virus. Am J Cardiol. 2003;91(12):1500–3, A9.

    Article  PubMed  Google Scholar 

  63. Robinson DJ, et al. Infective endocarditis in intravenous drug users: does HIV status alter the presenting temperature and white blood cell count? J Emerg Med. 2000;19(1):5–11.

    Article  CAS  PubMed  Google Scholar 

  64. Mestres CA, et al. Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1). Eur J Cardiothorac Surg. 2003;23(6):1007–16; discussion 1016.

    Article  PubMed  Google Scholar 

  65. Polanco A, et al. Changing prevalence, profile, and outcomes of patients with HIV undergoing cardiac surgery in the United States. Am Heart J. 2014;167(3):363–8.

    Article  PubMed  Google Scholar 

  66. Fowler Jr VG, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293(24):3012–21.

    Article  CAS  PubMed  Google Scholar 

  67. Selton-Suty C, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9.

    Article  PubMed  Google Scholar 

  68. Federspiel JJ, et al. Increasing US rates of endocarditis with Staphylococcus aureus: 1999–2008. Arch Intern Med. 2012;172(4):363–5.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Ternhag A, et al. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8(7):e67519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Mourvillier B, et al. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med. 2004;30(11):2046–52.

    Article  PubMed  Google Scholar 

  71. Nienaber JJ, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013;57(10):1438–48.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine, Medical Microbiology and Community Health Sciences, Faculty of Health Sciences, University of Manitoba, 507, 745 Bannatyne Ave, Winnipeg, MB, R3E 0J9, Canada

    Yoav Keynan MD, PhD

  2. Section of Infectious Diseases, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada

    Ethan Rubinstein

Authors
  1. Yoav Keynan MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ethan Rubinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoav Keynan MD, PhD .

Editor information

Editors and Affiliations

  1. Heart Institute, University of Ottawa, Ottawa, Ontario, Canada

    Kwan-Leung Chan

  2. Department of Medicine, Health Sciences Centre, WINNIPEG, Manitoba, Canada

    John M. Embil

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing

About this chapter

Cite this chapter

Keynan, Y., Rubinstein, E. (2016). Changing Populations: The Elderly, Injection Drug Users, Health-Care Associated Endocarditis and Immunocompromised Patients. In: Chan, KL., Embil, J. (eds) Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-27784-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27784-4_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27782-0

  • Online ISBN: 978-3-319-27784-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation